Biocept Inc
BIOCDelisted Nov 20, 2023- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001044378
Biocept Inc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 18, 2022; 26 institutions reported holding it in 13F filings for Q1 2023, worth $304.2K in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Biocept Inc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
BIOC is no longer listed, and 13F filings after Q1 2023 list far fewer holders. See Q1 2023
- Institutional holders
- 13
- +2 vs. Q2 2023
- Shares held
- 174.7K
- +94.7K (+118.4%) vs. Q2 2023
- Total value
- $218.0K
- +$121.6K (+126.2%) vs. Q2 2023
- New holders
- 6
- 1 more added
- Sold out
- 4
- 1 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BIOC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 13 | $218.0K |
| Q2 2023 | 11 | $96.4K |
| Q1 2023 | 26 | $304.2K |
| Q4 2022 | 26 | $807.7K |
| Q3 2022 | 29 | $1.57M |
| Q2 2022 | 29 | $1.78M |
| Q1 2022 | 30 | $4.90M |
| Q4 2021 | 35 | $8.32M |
| Q3 2021 | 29 | $8.12M |
| Q2 2021 | 24 | $6.76M |
| Q1 2021 | 25 | $7.21M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Biocept Inc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 115 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 11 | $14 | 0.00% | +7+175.0% | Added |
| US Bancorp | 18 | $23 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 33 | $41 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 124 | $155 | 0.00% | +124 | New |
| Group One Trading, L.P. | 270 | $338 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,802 | $4.75K | 0.00% | −1,587−29.4% | Reduced |
| BlackRock Inc. | 5,261 | $6.58K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 10,406 | $13.0K | 0.00% | +10,406 | New |
| Geode Capital Management, LLC | 10,504 | $13.1K | 0.00% | +10,504 | New |
| Two Sigma Securities, LLC | 12,718 | $15.9K | 0.00% | +12,718 | New |
| Virtu Financial LLC | 13,777 | $17.0K | 0.00% | +13,777 | New |
| Alyeska Investment Group, L.P. | 117,647 | $147.1K | 0.00% | +117,647 | New |
| Anson Funds Management LP | 0 | $0 | 0.00% | −44,861−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −23,529−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −268−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −247−100.0% | Sold out |